United States Pharmacopeia

Private | Buy-Side | Pharmatech Associates

Independent scientific organization that collaborates with the world’s top experts in health and science to develop quality standards for medicines, dietary supplements, and food ingredients.

Case

Delancey Street Partners is pleased to announce that we served as exclusive financial advisor to United States Pharmacopeia (“USP” or the “Company”) in the acquisition of Pharmatech Associates, Inc (“PAI”). Delancey Street provided buy-side M&A advisory services to USP.

July 2021
USP
Acquisition of Pharmatech Associates, Inc (“PAI”)
Sector: Healthcare
Delancey Street Partners served as the exclusive financial advisor to United States Pharmacopeia

Delancey Street Partners is pleased to announce that we served as exclusive financial advisor to United States Pharmacopeia (“USP” or the “Company”) in the acquisition of Pharmatech Associates, Inc (“PAI”). Delancey Street provided buy-side M&A advisory services to USP.

About

July 2021
USP
Acquisition of Pharmatech Associates, Inc (“PAI”)
Sector: Healthcare
Delancey Street Partners served as the exclusive financial advisor to United States Pharmacopeia

Situation

United States Pharmacopeia is an independent scientific organization that collaborates with the world’s top experts in health and science to develop quality standards for medicines, dietary supplements, and food ingredients. USP’s quality standards are enforceable in the United States by the Food and Drug Administration and legally recognized in more than 50 countries. These standards, which are continuously developed and revised by more than 750 volunteer experts in science, industry, healthcare, and academia, are also used in more than 150 countries.

By adding Pharmatech Associates expertise, USP further advances its more than 200-year mission to help ensure access to quality medicines by extending services that assist manufacturers to meet global quality standards across the drug and product lifecycle.

The global medicine supply chain is a complex marketplace of manufacturers, suppliers, and distributors from many countries. Making it more resilient requires a multi-faceted approach. The acquisition of Pharmatech supports USP’s commitment to expand internal capabilities to strengthen the supply chain of quality medicines, builds on the Organization’s longstanding work with regulators and manufacturers globally to solve some of the most critical and challenging problems in the industry, and helps ensure patients have access to the medicines that they need. Pharmatech helps manufacturers satisfy global regulatory requirements to bring products to market, scale up manufacturing, effectively manage quality control, and remediate quality problems in a rapidly changing environment.

Pharmatech Associates, Inc is a global consultancy for the life science industry, meeting the complex needs of clients with highly experienced scientists and engineering subject matter experts. Pharmatech’s team specializes in Product and Process Development, Facilities and Capital Projects, Quality Compliance, and Regulatory Affairs. Pharmatech advises clients that range in size from startups to large multi-national corporations on projects in Asia, Europe, and North America from its headquarters in the San Francisco Bay Area.

Result

The transaction was completed July 1, 2021.
The principals of Delancey Street Partners have significant experience serving the Healthcare industry.

For additional information about this transaction, please contact:

Additional

Information

The transaction was completed July 1, 2021.
The principals of Delancey Street Partners have significant experience serving the Healthcare industry.

For additional information about this transaction, please contact:

B. Andrew Schmucker

Managing Partner Phone: (484) 533 – 6313

B. Andrew Schmucker

Click to Email

William J. Filip

Managing Director Phone: (484) 533 – 6312

William J. Filip

Click to Email


We Work With

Great Companies

We want to work with you.

Contact us to learn how we can assist in maximizing the value of your business.